The schall law firm invites investors to lead the lifecore biomedical inc securities fraud lawsuit

Los angeles, ca / accesswire / august 14, 2024 / the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against lifecore biomedical, inc. ("lifecore" or "the company") (nasdaq:lfcr) for violations of 10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between october 7, 2020 and march 19, 2024, inclusive (the "class period"), are encouraged to contact the firm before september 27, 2024.
LFCR Ratings Summary
LFCR Quant Ranking